The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysis

BackgroundCurrently available treatment options for Parkinson's disease are symptomatic and do not alter the course of the disease. Recent studies have raised the possibility that cardiovascular risk management may slow the progression of the disease.ObjectivesWe estimated the effect of baselin...

Full description

Bibliographic Details
Main Authors: Max J. Oosterwegel, Jesse H. Krijthe, Melina G. H. E. den Brok, Lieneke van den Heuvel, Edo Richard, Tom Heskes, Bastiaan R. Bloem, Luc J. W. Evers
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1138546/full